Acuta Capital Partners’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-34,156
Closed -$4.26M 51
2021
Q3
$4.26M Hold
34,156
1.5% 18
2021
Q2
$4.28M Buy
34,156
+6,723
+25% +$843K 1.71% 19
2021
Q1
$3.72M Buy
+27,433
New +$3.72M 1.34% 32
2020
Q4
Sell
-78,807
Closed -$5.86M 55
2020
Q3
$5.86M Hold
78,807
1.59% 22
2020
Q2
$6.71M Hold
78,807
1.94% 20
2020
Q1
$5.7M Hold
78,807
2.76% 14
2019
Q4
$5.35M Buy
+78,807
New +$5.35M 1.32% 20